Stem Cell Authority, Ltd. (SCAL)
- Previous Close
0.0031 - Open
0.0031 - Bid --
- Ask --
- Day's Range
0.0031 - 0.0031 - 52 Week Range
0.0003 - 0.0080 - Volume
1,000 - Avg. Volume
524 - Market Cap (intraday)
3.01M - Beta (5Y Monthly) -51.28
- PE Ratio (TTM)
0.62 - EPS (TTM)
0.0050 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Stem Cell Authority, Ltd., a technology development company, focuses on the collection and cryogenic preservation of stem cells. It specializes in the collection and cryogenic preservation of the hematopoietic stem cells from the umbilical cord blood; and the Miracle Mesenchymal stem cells from the Wharton's jelly inside the umbilical cord of a newborn child. The company's technology enables birthing professionals with a stem cell preservation program to serve their maternity patients in the United States. Stem Cell Authority, Ltd. is based in Fairlawn, Ohio.
www.stemcellauthority.com--
Full Time Employees
August 31
Fiscal Year Ends
Sector
Industry
Related News
Performance Overview: SCAL
Trailing total returns as of 4/25/2024, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: SCAL
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: SCAL
Valuation Measures
Market Cap
3.01M
Enterprise Value
3.01M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
55.06%
Return on Assets (ttm)
49.09%
Return on Equity (ttm)
--
Revenue (ttm)
3.33M
Net Income Avi to Common (ttm)
1.83M
Diluted EPS (ttm)
0.0050
Balance Sheet and Cash Flow
Total Cash (mrq)
39.84k
Total Debt/Equity (mrq)
488.28%
Levered Free Cash Flow (ttm)
--
Company Insights: SCAL
SCAL does not have Company Insights